9
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Scedosporium apiospermumkeratitis treated with itraconazole

, , &
Pages 111-114 | Published online: 09 Jul 2009

References

  • Kwon-Chung KJ, Bennett JE (eds). Medical Mycology. Phila-delphia: Lea & Febiger, 1992.
  • Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000; 13: 662–685.
  • D'Hondt K, Parys-Van Ginderdeuren R, Foets BB. Fungal keratitis caused by Pseudallescheria boydii (Scedosporium apiospermum). Bull Soc Belge Ophtalmol 2000; 277: 53–56.
  • Del Palacio A, Perez-Blazquez E, Cuetara MS, Bravo MG, Criado D, Gimeno C, Noriega AR. Keratomycosis due to Scedosporium apiospermum. Mycoses 1991; 34: 483–487.
  • Firdova M, Tkacova E, Jesenska Z, Minova M. Mycotic keratitis with uveitis caused by Scedosporium apiospermum. Cesk Slov Oftalmol 1997; 53: 248–251.
  • Ksiazek SM, Morris DA, Mandelbaum S, Rosenbaum PS. Fungal panophthalmitis secondary to Scedosporium apiosper-mum (Pseudallescheria boydii) keratitis. Am J Ophthalmol1994; 118: 531–533.
  • Levitt JIM, Goldenstein J. Keratomycosis due to Allescheria boydii. Am J Ophthalmol 1971; 71: 1190–1191.
  • Rumelt S, Cohen 1, Lefler E, Rehany U. Corneal co-infection with Scedosporium apiospermum and Acanthamoeba after sewage-contaminated ocular injury. Cornea 2001; 20: 112–116.
  • Rippon JW. Pseudallescheriasis. In: Rippon JW, ed. Medical Mycology, 3rd edn. Philadelphia: WB Saunders Co., 1988: 651–680.
  • Roberson MC. Fungal keratitis. In: Freunfelder FT, Roy FH, eds. Current ocular therapy, 4th edn. Philadelphia: WB Saunders Co., 1995: 492–494.
  • Jones DB. Diagnosis and management of fungal keratitis. In: Tasman W., Jaeger EA, eds. Duane's Clinical Ophthalmology. Clinical Volume 4, chapter 21. CD-ROM edition. Philadelphia: Lippincott, Williams and Wilkins Publishers Inc., 2000.
  • National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed Stan-dard M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • Sutton DA, Fothergill AW, Rinaldi MG (eds). Guide to Clinically Significant Fungi. Baltimore: Williams & Wilkins, 1998.
  • Garg P, Gopinathan U, Choudhury K, Rao ON. Keratomycosis: clinical and microbiological experience with dematiaceous fungi. Ophthalmology 2000; 107: 574–580.
  • Espinel-lngroff A. Comparison of E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 2001; 39: 1360–1367.
  • Espinel-lngroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic mon-iliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954–958.
  • Girmenia C, Luzi G, Monaco M, Martino P. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol 1998; 36: 1436–1438.
  • McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR, Jr. Rinaldi MG. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother 1997; 41: 1832–1834.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.